Nivolumab (nivo) vs investigators choice (IC) for recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): CheckMate-141 [abstract]
investigated the effects of GLP-1(9-36), a metabolite produced by N- terminal dipeptide cleavage of native GLP-1(7-36), which exhibits very low affinity for the GLP-1-receptor, in comparison to GLP-1(7-36) and liraglutide
Rapid weight changes associated with starting or stopping GLP-1 treatment challenge traditional risk metrics such as body mass index
TMs 3-6 and the intracellular halves of TM1, TM2 and TM7 of the GLP-1(9-36)-bound GLP-1R align well with that bound by GLP-1(7-36), indicating a conserved TMD architecture ( Fig
Research will continue to explore how dietary patterns affect health in different populations, but for most people, worrying about seed oils is less helpful than improving overall diet quality
Sixth, for CKD and oncology patients, the documented link between the chronic condition and the anemia
